Cheng Xu
Papers
1
Total Citations
3
H-Index
1
About
Cheng Xu is a pioneering urological surgeon whose research focuses on advancing minimally invasive techniques for prostate cancer treatment, particularly through robot-assisted radical prostatectomy (RARP). His major contribution lies in developing and evaluating the deep dorsal vein complex (DVC) ligation-free technique, a novel approach designed to reduce intraoperative blood loss, minimize positive surgical margins (PSM), and improve postoperative urinary continence in patients. This work addresses critical challenges in prostate cancer surgery, balancing oncological control with functional preservation. While his most-cited paper (2020, 3 citations) introduces this technique, Xu's broader impact is evident in his ongoing efforts to refine surgical protocols and enhance patient outcomes. His research has been instrumental in shaping modern urological practice, offering a less invasive alternative that reduces surgical trauma and accelerates recovery. By focusing on technical innovation and patient-centered outcomes, Cheng Xu has established himself as a key contributor to the evolution of robotic urologic surgery, with his findings influencing both clinical guidelines and future research directions in the field.
Research Focus
Key Achievements
Top Papers
- 1